cognitive impairment, sleep disorder, Parkinson's disease
Conditions
Interventions
Case series:None
Sponsors
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
Eligibility
Sex/Gender
All
Age
60 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1.COVID group 1)Hospitalized patients with confirmed COVID-19; 2)Chinese citizens, over 60 years old and under 85 years old, no gender restrictions; 3)The patient has good general health, stable physical conditions, and can be completed independently assessed using all scales; 4)The patient fully knowledges of this study, has good compliance, writes informed consent, and consents to have long-term follow-up evaluations. 2. Normal control group 1)Chinese citizens, over 60 years old and under 85 years old, no gender restrictions; 2)The patient has good general health, stable physical conditions, and can be completed independently assessed using all scales; 4)The patient fully knowledges of this study, has good compliance, writes informed consent, and consents to have long-term follow-up evaluations.
Exclusion criteria
Exclusion criteria: Subjects meeting any of the following criteria will be excluded from this study: 1)have dementia or other cognitive impairments; 2)have pulmonary embolism, osteoarthritis, or other causes of inability to move freely; 3)have severe underlying diseases or tumor history which affect follow-ups; 4)Those who cannot understand the procedures or methods of this clinical study, refuse to participate, or refuse to sign the informed consent forms.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| MMSE;Anxiety and Depression Scales;Non-motor Symptom Screening Scale;RBD scale;Sleep quality index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Wexner Constipation Scale;24h water volume in and out; | — |
Countries
China
Contacts
Public ContactXiaodan Wang
Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Outcome results
None listed